Global beauty company L’Oréal signed a contract with domestic bio company OliX on June 29 to discover ‘short interfering ...

"Our study builds on the discovery of RNA interference, for which the Nobel Prize in Medicine was awarded in 2006. While siRNA therapies have already been used for genetic diseases, our work is the ...

Cross-kingdom RNA interference encompasses the bidirectional transfer of RNA molecules between plants and their pathogens, enabling one organism to modulate gene expression in another. Fungal and ...

– Company Expects to Initiate a Phase 1/2 Study for ALN-KHK in Early 2023, with Initial Results Expected in Late 2023 – “We are excited to advance ALN-KHK to the clinic as our first RNAi therapeutic ...

Protecting plants efficiently against pests without harming other organisms—this is the objective of the joint research project ViVe_Beet, which is coordinated by the Julius Kühn Institute (JKI).

Gene knockdown is a common method for studying gene function by reducing messenger ribonucleic acid (mRNA) levels without altering the deoxyribonucleic acid (DNA). Among the available techniques, RNA ...